Armenia. Local Armenian pharmaceutical manufacturers 2007-2010
1. Total sales of Armenian pharmaceutical companies 2009-2010
2. Sales distribution by DOMESTIC MARKET vs. EXPORTS
3. Change in export volumes
4. Export COUNTRIES and their TOP 10 (According to official statistics)
5. Change in number of employees
6. Marketing subdivisions and the change in number of their employees
7. Change of marketing budget
The main conclusions describing dynamics of indicators of Armenian pharmaceutical enterprises’ operation for 2008-2010 are the following.
Despite the global financial-economic crisis, Armenian pharmaceutical enterprises have ensured impressive results in the pharmaceutical sphere. Sales of the main large enterprises, except Vitamax-E, have increased. Hagenas has potential to become one of relatively large enterprises.
According to the results of 2010, in the sales of 5 enterprises (out of 9) export is dominant.
Among the surveyed enterprises only in case of Vitamax-E there is notable decrease in export volumes. In case of other enterprises there is relative stability and increase in export volumes. Liqvor and Arpimed are among those enterprises.
According to official statistics, during the years of global financial-economic crisis volumes of Armenian pharmaceutical exports have increased (by 25% in 2007-2009). Centralization of export market is noted. The main three markets of Armenian pharmaceutical products are Georgia, Russia and Uzbekistan.
According to aggregation of results of 9 pharmaceutical enterprises, the number of field employees has grown by 7% in 2008-2010. Among the mentioned enterprises only in case of Hagenas and Bizon-1 there was a reduction of employees’ number.
6 out of 9 surveyed enterprises sell their products through separate marketing subdivisions. During the period of 2008-2010 in all the mentioned 6 enterprises the number of marketing subdivisions’ employees has increased or remained the same. Budgets of marketing activities have increased in all 6 enterprises.
2. Sales distribution by DOMESTIC MARKET vs. EXPORTS
3. Change in export volumes
4. Export COUNTRIES and their TOP 10 (According to official statistics)
5. Change in number of employees
6. Marketing subdivisions and the change in number of their employees
7. Change of marketing budget
The main conclusions describing dynamics of indicators of Armenian pharmaceutical enterprises’ operation for 2008-2010 are the following.
Despite the global financial-economic crisis, Armenian pharmaceutical enterprises have ensured impressive results in the pharmaceutical sphere. Sales of the main large enterprises, except Vitamax-E, have increased. Hagenas has potential to become one of relatively large enterprises.
According to the results of 2010, in the sales of 5 enterprises (out of 9) export is dominant.
Among the surveyed enterprises only in case of Vitamax-E there is notable decrease in export volumes. In case of other enterprises there is relative stability and increase in export volumes. Liqvor and Arpimed are among those enterprises.
According to official statistics, during the years of global financial-economic crisis volumes of Armenian pharmaceutical exports have increased (by 25% in 2007-2009). Centralization of export market is noted. The main three markets of Armenian pharmaceutical products are Georgia, Russia and Uzbekistan.
Pharmaceutical field stands out among other economic branches of Armenia with the increase of its export indicators.
According to aggregation of results of 9 pharmaceutical enterprises, the number of field employees has grown by 7% in 2008-2010. Among the mentioned enterprises only in case of Hagenas and Bizon-1 there was a reduction of employees’ number.
6 out of 9 surveyed enterprises sell their products through separate marketing subdivisions. During the period of 2008-2010 in all the mentioned 6 enterprises the number of marketing subdivisions’ employees has increased or remained the same. Budgets of marketing activities have increased in all 6 enterprises.
Leave a Comment